Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets.

This study explores how different chemicals interact with horse platelet cells in relation to certain equine diseases. These interactions are observed in vitro, focusing on platelet aggregation and the production and release of certain substances in response to platelet activation.

Research Objectives

• Platelets are believed to contribute to equine diseases like acute laminitis, verminous arteritis, and potentially, allergic diseases. This research examined how certain substances – 5-HT, histamine, ADP, and PAF – interact with equine platelets, which may provide insights into their role in these diseases.
• The aim of the study was to understand the effects of these substances, both individually and in combination, on the aggregation of platelets, the production of thromboxane, and the release of radioactive 5-HT.

Key Findings

• PAF was found to cause a concentration-related aggregation in platelets and resulted in increased release of radioactive 5-HT and production of thromboxane.
• ADP was found to mainly cause platelet aggregation, while 5-HT induced the release of radioactive 5-HT, with little effect on the other functions of platelets.
• Histamine was found to have little or no effect on horse platelets.
• The research also found that the introduction of 5-HT before ADP significantly displaced the aggregation response curve to the left, suggesting that these substances may interact in ways that could impact thromboembolic diseases in horses.

Implications and Conclusions

• The differential responses of platelets to PAF, ADP, and 5-HT suggest that these substances might activate different intracellular signaling pathways regulating platelet functions.
• This understanding could have implications in managing thromboembolic diseases in horses, as the interactions between these mediators could enhance certain platelet responses, potentially contributing to disease pathogenesis.
• This work adds new perspectives to our current understanding of equine platelet responses and may assist in developing more effective strategies for managing equine diseases associated with platelet function.